111 related articles for article (PubMed ID: 16866301)
1. Primary glioblastoma with EGFR amplification and a ring chromosome 7 in a young patient.
Lopez-Gines C; Cerdá-Nicolás M; Gil-Benso R; Pellin A; López-Guerrero JA; Benito R; del Rey J; Miró R; Roldan R; Barberá J
Clin Neuropathol; 2006; 25(4):193-9. PubMed ID: 16866301
[TBL] [Abstract][Full Text] [Related]
2. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme.
Lopez-Gines C; Cerda-Nicolas M; Gil-Benso R; Pellin A; Lopez-Guerrero JA; Callaghan R; Benito R; Roldan P; Piquer J; Llacer J; Barbera J
Clin Neuropathol; 2005; 24(5):209-18. PubMed ID: 16167544
[TBL] [Abstract][Full Text] [Related]
3. Genetic analyses for predictors of radiation response in glioblastoma.
Shih HA; Betensky RA; Dorfman MV; Louis DN; Loeffler JS; Batchelor TT
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):704-10. PubMed ID: 15978739
[TBL] [Abstract][Full Text] [Related]
4. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
[TBL] [Abstract][Full Text] [Related]
5. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.
Miyanaga T; Hirato J; Nakazato Y
Neuropathology; 2008 Apr; 28(2):116-26. PubMed ID: 18021194
[TBL] [Abstract][Full Text] [Related]
6. The activation of ERK1/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFR amplification.
Lopez-Gines C; Gil-Benso R; Benito R; Mata M; Pereda J; Sastre J; Roldan P; Gonzalez-Darder J; Cerdá-Nicolás M
Neuropathology; 2008 Oct; 28(5):507-15. PubMed ID: 18410277
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
[TBL] [Abstract][Full Text] [Related]
8. Incidence of the main genetic markers in glioblastoma multiforme is independent of tumor topology.
Necesalová E; Vranová V; Kuglík P; Cejpek P; Jarosová M; Pesáková M; Relichová J; Veselská R
Neoplasma; 2007; 54(3):212-8. PubMed ID: 17447852
[TBL] [Abstract][Full Text] [Related]
9. Novel amplicons on the short arm of chromosome 7 identified using high resolution array CGH contain over expressed genes in addition to EGFR in glioblastoma multiforme.
Rossi MR; La Duca J; Matsui S; Nowak NJ; Hawthorn L; Cowell JK
Genes Chromosomes Cancer; 2005 Dec; 44(4):392-404. PubMed ID: 16110500
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
Actor B; Cobbers JM; Büschges R; Wolter M; Knobbe CB; Lichter P; Reifenberger G; Weber RG
Genes Chromosomes Cancer; 2002 Aug; 34(4):416-27. PubMed ID: 12112531
[TBL] [Abstract][Full Text] [Related]
11. The infrequent simultaneous genetic alterations in glioblastoma multiforme (LOH 10, 17, 19q, TP53 mutation and EGFR amplification) with short clinical course.
Jesionek-Kupnicka D; Kulczycka D; Rieske P; Szybka M; Jabłońska J; Potemski P; Kolasa P; Liberski PP; Kordek R
Pol J Pathol; 2007; 58(2):79-85. PubMed ID: 17715673
[TBL] [Abstract][Full Text] [Related]
12. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
[TBL] [Abstract][Full Text] [Related]
13. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
Eoli M; Menghi F; Bruzzone MG; De Simone T; Valletta L; Pollo B; Bissola L; Silvani A; Bianchessi D; D'Incerti L; Filippini G; Broggi G; Boiardi A; Finocchiaro G
Clin Cancer Res; 2007 May; 13(9):2606-13. PubMed ID: 17473190
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic analysis of deep-seated glioblastomas.
Hayashi Y; Yamashita J; Watanabe T
Cancer Genet Cytogenet; 2004 Aug; 153(1):64-8. PubMed ID: 15325097
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations in a papillary glioneuronal tumor.
Faria C; Miguéns J; Antunes JL; Barroso C; Pimentel J; Martins Mdo C; Moura-Nunes V; Roque L
J Neurosurg Pediatr; 2008 Jan; 1(1):99-102. PubMed ID: 18352813
[TBL] [Abstract][Full Text] [Related]
17. Distribution of epidermal growth factor receptor protein correlates with gain in chromosome 7 revealed by comparative genomic hybridization after microdissection in glioblastoma multiforme.
Romeike BF; Jung V; Feiden W; Moringlane JR; Zang KD; Urbschat SM
Pathol Res Pract; 2001; 197(6):427-31. PubMed ID: 11432670
[TBL] [Abstract][Full Text] [Related]
18. Gene amplification in human gliomas.
Collins VP
Glia; 1995 Nov; 15(3):289-96. PubMed ID: 8586464
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of two cell lines derived from human glioblastoma multiforme.
Bacciocchi G; Gibelli N; Zibera C; Pedrazzoli P; Bergamaschi G; De Piceis Polver P; Danova M; Mazzini G; Palomba L; Tupler R
Anticancer Res; 1992; 12(3):853-61. PubMed ID: 1320358
[TBL] [Abstract][Full Text] [Related]
20. FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma.
Nagasaka T; Gunji M; Hosokai N; Hayashi K; Ikeda H; Ito M; Inao S
Brain Tumor Pathol; 2007; 24(1):1-5. PubMed ID: 18095137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]